StockWatch
·
Biotechnology: Pharmaceutical Preparations
Insider TradingNov 5, 2026, 01:11 PM

Novo Nordisk Executive Sells DKK 3.42M in Shares

AI Summary

Novo Nordisk A/S disclosed insider trading activity involving Executive Vice President Martin Holst Lange. He sold 12,000 shares of Novo Nordisk B stock on November 4, 2026, at a price of DKK 285.00 per share, for a total value of DKK 3,420,000.00. The transaction was executed on Nasdaq Copenhagen and is reported in accordance with market abuse regulations.

Key Highlights

  • Executive Vice President Martin Holst Lange sold 12,000 Novo Nordisk shares.
  • The sale occurred on November 4, 2026, at a price of DKK 285.00 per share.
  • Total transaction value was DKK 3,420,000.00.
  • The transaction took place on Nasdaq Copenhagen.